Wednesday, August 13, 2008

Anthera Pharmaceuticals Raises $19M

San Mateo-based Anthera Pharmaceuticals announced Wednesday that the firm has raised $19M in an equity financing for the firm's anti-inflammatory drugs. The funding came from Caxton Advantage Life Sciences Fund and HBM BioCapital, which led the round. Existing investors VantagePoint Venture Partners, Sofinnova Ventures, Pappas Ventures and Mitsubishi International Corporation also participated. Anthera said that Rachel Leheny, Ph.D. of Caxton will join the firm's board as part of the funding. More information »